Surface plasmon resonance biosensor combined with lentiviral particle stabilization strategy for rapid and specific screening of P-Glycoprotein ligands

Abstract

A novel surface plasmon resonance–based P-gp ligand screening system (SPR-PLSS) combined with lentiviral particle (LVP) stabilization strategy was constructed to screen out potential P-gp inhibitors from natural products. Firstly, we constructed LVPs with high and low expression levels of P-gp. The LVPs can ensure the natural conformation of P-gp based on the principle that LVPs germinated from packaging cells will contain cell membrane fragments and P-gp they carry. Then the LVPs with high P-gp expression for active channel and LVPs with low P-gp expression for reference channel were immobilized on CM5 chip respectively. The affinity detection was thus carried out with the signal reduction on the two channels. The P-gp inhibitors, Valspodar (Val) and cyclosporin (CsA), as positive compounds, were detected to characterize the chip’s activity, and the KD of Val and CsA were 14.09 μM and 16.41 μM, respectively. Forty compounds from natural product library were screened using the SPR CM5 chip, and magnolol (Mag), honokiol (Hon), and resveratrol (Res) were screened out as potential P-gp ligands, showing a significant response signal. This work presented a novel P-gp ligand screening system based on LVP-immobilized biosensor to rapidly screen out P-gp ligands from natural product library. Compared with traditional cell experiments which the screening time may take up to several days, our method only takes several hours. Furthermore, this study has also provided solid evidences to support that some complicated membrane proteins would apply to the lentivirus-based SPR screening system.

Graphical abstract

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

References

  1. 1.

    Kim Y, Chen J. Molecular structure of human P-glycoprotein in the ATP-bound, outward-facing conformation. Science. 2018;359(6378):915–9.

    CAS  Article  Google Scholar 

  2. 2.

    Ferreira RJ, dos Santos DJ, Ferreira MJ. P-glycoprotein and membrane roles in multidrug resistance. Future Med Chem. 2015;7(7):929–46.

    CAS  Article  Google Scholar 

  3. 3.

    Robey RW, Pluchino KM, Hall MD, Fojo AT, Bates SE, Gottesman MM. Revisiting the role of ABC transporters in multidrug-resistant cancer. Nat Rev Cancer. 2018;18(7):452–64.

    CAS  Article  Google Scholar 

  4. 4.

    Leopoldo M, Nardulli P, Contino M, Leonetti F, Luurtsema G, Colabufo NA. An updated patent review on P-glycoprotein inhibitors (2011-2018). Expert Opin Ther Pat. 2019;29(6):455–61.

    CAS  Article  Google Scholar 

  5. 5.

    Ma X, Hu M, Wang H, Li J. Discovery of traditional Chinese medicine monomers and their synthetic intermediates, analogs or derivatives for battling P-gp-mediated multi-drug resistance. Eur J Med Chem. 2018;159:381–92.

    CAS  Article  Google Scholar 

  6. 6.

    Pan X, Mei H, Qu S, Huang S, Sun J, Yang L, et al. Prediction and characterization of P-glycoprotein substrates potentially bound to different sites by emerging chemical pattern and hierarchical cluster analysis. Int J Pharm. 2016;502(1–2):61–9.

    CAS  Article  Google Scholar 

  7. 7.

    Browning LM, Lee KJ, Cherukuri PK, Huang T, Songkiatisak P, Warren S, et al. Single gold nanoparticle plasmonic spectroscopy for study of chemical-dependent efflux function of single ABC transporters of single live Bacillus subtilis cells. Analyst. 2018;143(7):1599–608.

    CAS  Article  Google Scholar 

  8. 8.

    Xia X, Cole SPC, Cai T, Cai Y. Effect of traditional Chinese medicine components on multidrug resistance in tumors mediated by P-glycoprotein. Oncol Lett. 2017;13(6):3989–96.

    CAS  Article  Google Scholar 

  9. 9.

    Chiba P, Ecker G, Schmid D, Drach J, Tell B, Goldenberg S, et al. Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multidrug resistance. Mol Pharmacol. 1996;49(6):1122–30.

    CAS  PubMed  Google Scholar 

  10. 10.

    Conseil G, Baubichon-Cortay H, Dayan G, Jault JM, Barron D, Di Pietro A. Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein. Proc Natl Acad Sci U S A. 1998;95(17):9831–6.

    CAS  Article  Google Scholar 

  11. 11.

    Suzuki T, Fukazawa N, San-nohe K, Sato W, Yano O, Tsuruo T. Structure-activity relationship of newly synthesized quinoline derivatives for reversal of multidrug resistance in cancer. J Med Chem. 1997;40(13):2047–52.

    CAS  Article  Google Scholar 

  12. 12.

    Feng B, Mills JB, Davidson RE, Mireles RJ, Janiszewski JS, Troutman MD, et al. In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system. Drug Metab Dispos. 2008;36(2):268–75.

    CAS  Article  Google Scholar 

  13. 13.

    Food U, Evaluation DAJCfD, research. Guidance for industry: drug interaction studies—study design, data analysis, implications for dosing, and labeling recommendations 2012:1–75.

  14. 14.

    Zang X, Wang G, Cai Q, Zheng X, Zhang J, Chen Q, et al. A promising microtubule inhibitor deoxypodophyllotoxin exhibits better efficacy to multidrug-resistant breast cancer than paclitaxel via avoiding efflux transport. Drug Metab Dispos. 2018;46(5):542–51.

    CAS  Article  Google Scholar 

  15. 15.

    O'Brien FE, Dinan TG, Griffin BT, Cryan JF. Interactions between antidepressants and P-glycoprotein at the blood-brain barrier: clinical significance of in vitro and in vivo findings. Br J Pharmacol. 2012;165(2):289–312.

    CAS  Article  Google Scholar 

  16. 16.

    Klepsch F, Chiba P, Ecker GF. Exhaustive sampling of docking poses reveals binding hypotheses for propafenone type inhibitors of P-glycoprotein. PLoS Comput Biol. 2011;7(5):e1002036.

    CAS  Article  Google Scholar 

  17. 17.

    Vilar S, Sobarzo-Sánchez E, Uriarte E. In silico prediction of P-glycoprotein binding: insights from molecular docking studies. Curr Med Chem. 2019;26(10):1746–60.

    CAS  Article  Google Scholar 

  18. 18.

    Wang XY, Ding X, Yuan YF, Zheng LY, Cao Y, Zhu ZY, et al. Comprehensive two-dimensional APTES-decorated MCF7-cell membrane chromatographic system for characterizing potential anti-breast-cancer components from Yuanhu-Baizhi herbal medicine pair. J Food Drug Anal. 2018;26(2):823–33.

    Article  Google Scholar 

  19. 19.

    Cao Y, Li YH, Lv DY, Chen XF, Chen LD, Zhu ZY, et al. Identification of a ligand for tumor necrosis factor receptor from Chinese herbs by combination of surface plasmon resonance biosensor and UPLC-MS. Anal Bioanal Chem. 2016;408(19):5359–67.

    CAS  Article  Google Scholar 

  20. 20.

    Vega B, Muñoz LM, Holgado BL, Lucas P, Rodríguez-Frade JM, Calle A, et al. Technical advance: surface plasmon resonance-based analysis of CXCL12 binding using immobilized lentiviral particles. J Leukoc Biol. 2011;90(2):399–408.

    CAS  Article  Google Scholar 

  21. 21.

    Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, et al. A third-generation lentivirus vector with a conditional packaging system. J Virol. 1998;72(11):8463–71.

    CAS  Article  Google Scholar 

  22. 22.

    Heym RG, Hornberger WB, Lakics V, Terstappen GC. Label-free detection of small-molecule binding to a GPCR in the membrane environment. Biochim Biophys Acta. 2015;1854(8):979–86.

    CAS  Article  Google Scholar 

  23. 23.

    Martínez-Muñoz L, Barroso R, Paredes AG, Mellado M, Rodríguez-Frade JM. Methods to immobilize GPCR on the surface of SPR sensors. Methods Mol Biol. 2015;1272:173–88.

    Article  Google Scholar 

  24. 24.

    Fischer MJ. Amine coupling through EDC/NHS: a practical approach. Methods Mol Biol. 2010;627:55–73.

    CAS  Article  Google Scholar 

  25. 25.

    Agarwal S, Sane R, Ohlfest JR, Elmquist WF. The role of the breast cancer resistance protein (ABCG2) in the distribution of sorafenib to the brain. J Pharmacol Exp Ther. 2011;336(1):223–33.

    CAS  Article  Google Scholar 

  26. 26.

    Liu Y, Liu R, Yang F, Cheng R, Chen X, Cui S, et al. miR-19a promotes colorectal cancer proliferation and migration by targeting TIA1. Mol Cancer. 2017;16(1):53.

    Article  Google Scholar 

  27. 27.

    Demeule M, Laplante A, Murphy GF, Wenger RM, Béliveau R. Identification of the cyclosporin-binding site in P-glycoprotein. Biochemistry. 1998;37(51):18110–8.

    CAS  Article  Google Scholar 

  28. 28.

    Battle TE, Arbiser J, Frank DA. The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. Blood. 2005;106(2):690–7.

    CAS  Article  Google Scholar 

  29. 29.

    Wang L, Wang C, Jia Y, Liu Z, Shu X, Liu K. Resveratrol increases anti-proliferative activity of bestatin through downregulating P-glycoprotein expression via inhibiting PI3K/Akt/mTOR pathway in K562/ADR cells. J Cell Biochem. 2016;117(5):1233–9.

    CAS  Article  Google Scholar 

Download references

Funding

This research was supported by the National Natural Science Foundation of China (No.81673386, 81872829).

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Zhanying Hong or Yifeng Chai.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

ESM 1

(PDF 534 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Cao, Y., Cao, Y., Shi, Y. et al. Surface plasmon resonance biosensor combined with lentiviral particle stabilization strategy for rapid and specific screening of P-Glycoprotein ligands. Anal Bioanal Chem (2021). https://doi.org/10.1007/s00216-021-03170-5

Download citation

Keywords

  • P-Glycoprotein
  • Multidrug resistance
  • Lentiviral particles
  • Surface plasmon resonance
  • Screening system
  • Natural products